Talcum Powder Lawsuit News Source Harris Martin To Host Conference

The legal news publisher Harris Martin, which posts a number of talcum powder ovarian cancer lawsuit news stories on its website, announced that it will hold a talcum powder conference in Charleston, South Carolina on May 17.

Friday, February 19, 2016 - Harris Martin, a legal publication that has written about talcum powder ovarian cancer lawsuit news, has announced that it will hold a conference concerning talcum powder and ovarian cancer. The conference is scheduled to take place on May 17 in Charleston, South Carolina. Those present at the conference will be involved in a number of activities and presentations concerning the more than 1,000 talcum powder lawsuits currently pending nationwide.

The conference will cost $695 per registrant until April 15, after which the price will increase to $795. The conference also offers packages for parties interested in exhibiting displays at the conference. The exhibitor packages range from a one-time appearance to annual sponsorship deals. The exhibition package details include a customizable table upon which to build your presentation for conference attendees, as well as the ability to make a special announcement from the conference podium.

The conference is being planned as talcum powder cancer lawsuit news is spreading around the county with plaintiffs alleging that talcum powder manufacturer Johnson & Johnson (J&J) knew of the ovarian cancer risks involved with their products and decided against warning consumers of the potential dangers. The plaintiffs have claimed that J&J may have been aware of the significant link between talcum powder and an increased risk in ovarian cancer for women who used their products genitally for more than a decade, but withheld it from the public to protect the marketability of their talcum powder revenues.

More than 20 medical studies dating back to 1971 have found that a positive correlation between talcum powder and ovarian cancer exists, with some research pegging the increased risk of ovarian cancer contraction at more than 30 percent. These studies are being employed by plaintiffs as hard evidence of a connection between talcum powder and ovarian cancer and claim that there is no way that J&J wouldn't have been aware of these published records. The plaintiffs also claim to have internal documents proving that J&J was aware of the link between talcum powder and ovarian cancer, but did not release their findings to consumers.

J&J has argued that it has relied on its own studies it discovered that claim there is not a significant link between talcum powder and ovarian cancer. They also pointed to the International Agency for Research on Cancer and the Food and Drug Administration's standoffish statements on talcum powder's relationship to ovarian cancer. Both agencies claim that while a link may exist, they have not compiled the evidence necessary to take a hard stance on the issue.

More than 1,000 lawsuits have been filed around the country, however, that claim that hard evidence is in their possession and will prove that talcum powder can lead to an increased risk of ovarian cancer and that J&J was aware of the severity of the danger posed to consumers. 130 alone have been filed in multicounty litigation currently underway in New Jersey, where J&J is headquartered. More talcum powder lawsuit news is expected to accrue in the months leading up to the Harris Martin talcum powder conference, which may indicate why a hard agenda has yet to be posted on the events main website.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.